BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33300654)

  • 21. Toxicities of chemoradiotherapy and radiotherapy in nasopharyngeal carcinoma: an updated meta-analysis.
    Wang C; Wang F; Min X; Zhang Q; Shen LJ; Jiang Y; Yan J
    J Int Med Res; 2019 Jul; 47(7):2832-2847. PubMed ID: 31272262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the NCI-CTCAE version 4.0 and version 3.0 in assessing chemoradiation-induced oral mucositis for locally advanced nasopharyngeal carcinoma.
    Liu YJ; Zhu GP; Guan XY
    Oral Oncol; 2012 Jun; 48(6):554-9. PubMed ID: 22289637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials.
    Du CR; Ying HM; Kong FF; Zhai RP; Hu CS
    Radiat Oncol; 2015 Mar; 10():70. PubMed ID: 25889937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase II Randomized Clinical Trial and Mechanistic Studies Using Improved Probiotics to Prevent Oral Mucositis Induced by Concurrent Radiotherapy and Chemotherapy in Nasopharyngeal Carcinoma.
    Xia C; Jiang C; Li W; Wei J; Hong H; Li J; Feng L; Wei H; Xin H; Chen T
    Front Immunol; 2021; 12():618150. PubMed ID: 33841399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of dose volume parameters and clinical factors on acute radiation oral mucositis for locally advanced nasopharyngeal carcinoma patients treated with concurrent intensity-modulated radiation therapy and chemoradiotherapy.
    Li K; Yang L; Xin P; Chen Y; Hu QY; Chen XZ; Chen M
    Oral Oncol; 2017 Sep; 72():32-37. PubMed ID: 28797459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute oral mucositis in nasopharyngeal carcinoma patients treated with radiotherapy: association with genetic polymorphism in DNA DSB repair genes.
    Ren JH; Dai XF; Yan GL; Jin M; Liu CW; Yang KY; Wu G; Ma CM
    Int J Radiat Biol; 2014 Mar; 90(3):256-61. PubMed ID: 24350917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probiotic
    Wang Y; Li J; Zhang H; Zheng X; Wang J; Jia X; Peng X; Xie Q; Zou J; Zheng L; Li J; Zhou X; Xu X
    Front Immunol; 2021; 12():684824. PubMed ID: 34149727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
    Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
    Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Potential Effect of Oral Microbiota in the Prediction of Mucositis During Radiotherapy for Nasopharyngeal Carcinoma.
    Zhu XX; Yang XJ; Chao YL; Zheng HM; Sheng HF; Liu HY; He Y; Zhou HW
    EBioMedicine; 2017 Apr; 18():23-31. PubMed ID: 28216066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of severe radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma using the combined systemic immune-inflammatory index and prognostic nutritional index.
    Song J; Wen Y; Liang L; Lv Y; Liu T; Wang R; Hu K
    Eur Arch Otorhinolaryngol; 2024 May; 281(5):2627-2635. PubMed ID: 38472492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas.
    Somay E; Yilmaz B; Topkan E; Ozdemir BS; Ozturk D; Besen AA; Mertsoylu H; Selek U
    Int J Biol Markers; 2024 Mar; 39(1):80-88. PubMed ID: 38192114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
    Wu L; Chung YL
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is skeletal muscle loss associated with chemoradiotherapy toxicity in nasopharyngeal carcinoma patients? A prospective study.
    Huang X; Lv LN; Zhao Y; Li L; Zhu XD
    Clin Nutr; 2021 Jan; 40(1):295-302. PubMed ID: 32507513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis.
    Zeng Q; Wang J; Lv X; Li J; Yin LJ; Xiang YQ; Guo X
    BMC Cancer; 2016 Aug; 16(1):693. PubMed ID: 27577729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric parameters predict radiation-induced choanal stenosis in patients with nasopharyngeal carcinoma.
    Chang H; Chen K; Tao YL; Han F; Ye WJ; Gao YH
    Radiat Oncol; 2020 Jun; 15(1):142. PubMed ID: 32503596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
    Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
    Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy.
    Alterio D; D'Ippolito E; Vischioni B; Fossati P; Gandini S; Bonora M; Ronchi S; Vitolo V; Mastella E; Magro G; Franco P; Ricardi U; Krengli M; Ivaldi G; Ferrari A; Fanetti G; Comi S; Tagliabue M; Verri E; Ricotti R; Ciardo D; Jereczek-Fossa BA; Valvo F; Orecchia R
    Acta Oncol; 2020 May; 59(5):541-548. PubMed ID: 32090645
    [No Abstract]   [Full Text] [Related]  

  • 38. Delayed complications of radiotherapy treatment for nasopharyngeal carcinoma: imaging findings.
    King AD; Ahuja AT; Yeung DK; Wong JK; Lee YY; Lam WW; Ho SS; Yu SC; Leung SF
    Clin Radiol; 2007 Mar; 62(3):195-203. PubMed ID: 17293211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion.
    Liao S; Xie Y; Feng Y; Zhou Y; Pan Y; Fan J; Mi J; Qin X; Yao D; Jiang W
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):429-439. PubMed ID: 31677113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma.
    Yang G; Feng D; Li F; Luo B; Zhu J; Yang Q; Zheng L; Dong Q; Chen M; Xu Z; Li L; Chen P; Sun J
    Radiother Oncol; 2021 Oct; 163():76-82. PubMed ID: 34343545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.